1. W. L. Chiou, S. Riegelman. Pharmaceutical
applications of solid dispersion systems, J. Pharm.
Sci. 60, 1281-1302 (1971).
2. J. L. Ford, A. F. Stewart, J. L. Dubois. The properties
of solid dispersions of indomethacin or
phenylbutazone in polyethylene glycol, Int. J.
Pharm. 28, 11-22 (1986).
3. C. Leuner, J. Dressman. Improving drug solubility
for oral delivery using solid dispersions, Eur J
Pharm Biopharm 50: 47-60 (2000).
4. A. H. Goldberg, M. Gibaldi, J. L. Kanig. Increasing
dissolution rates and gastrointestinal absorption of
drugs via solid solutions and eutectic mixtures I -
theoretical considerations and discussion of the
literature, J. Pharm. Sci. 54: 1145-1148 (1965).
5. A. H. Goldberg, M. Gibaldi, J. L. Kanig. Increasing
dissolution rates and gastrointestinal absorption of
drugs via solid solutions and eutectic mixtures II -
experimental evaluation of a eutectic mixture: ureaacetaminophen
system, J. Pharm. Sci. 55: 482-487
(1966).
6. K. Sekiguchi, N. Obi. Studies on absorption of
eutectic mixtures, I. A comparison of the behavior of
eutectic mixtures of sulphathiazole and that of
ordinary sulphathiazole in man, Chem. Pharm. Bull.
9: 866-872 (1961).
7. G. Levy. Effect of particle size on dissolution and
gastrointestinal absorption rates of
pharmaceuticals, Am. J. Pharm. 135: 78 – 92 (1963).
8. J. L. Kanig. Properties of fused mannitol in
compressed tablets, J. Pharm. Sci. 53: 188-192
(1964).
9. T. Tachibana, A. Nakamura. A method for preparing
an aqueous colloidal dispersion of organic materials
by using water-soluble polymers: dispersion of
beta-carotene by polyvinyl pyrrolidone, Kolloid-Z.
Polym. 203: 130-133 (1965).
10. M. Mayersohn, M. Gibaldi. New method of solidstate
dispersion for increasing dissolution rates, J.
Pharm. Sci. 55: 1323-1324 (1966).
11. W. L. Chiou, S. Riegelman. Preparation and
dissolution characteristics of several fast-release
solid dispersions of griseofulvin, J. Pharm. Sci. 58:
1505-1510 (1969).
12. A. Paradkar, A. Ambike, B. Jadhav, K. Mahadik.
Characterization of curcumin- PVP solid dispersion
obtained by spray drying, International Journal of
Pharmaceutics 271: 281– 286 (2004).
13. K. Sekiguchi, N. Obi, Y. Ueda. Studies on absorption
of eutectic mixtures, II. Absorption of fused
conglomerates of chloramphenicol and urea in
rabbits, Chem. Pharm. Bull. 12: 134-144 (1964).
14. A. P. Simonelli, S. C. Metha, W. I. Higuchi. Dissolution
rates of high energy polyvinylpyrrolidone (PVP)-
sulfathiazole coprecipitates, J. Pharm. Sci. 58: 538-
549 (1969).
15. V. Majerik. Bioavailability enhancement of an active
substance by supercritical antisolvent precipitation,
J. Supercrit. Fluids 40: 101–110 (2007).
16. F. Damian, N. Blaton, L. Naesens, J. Balzarini, R.
Kinget, P. Augustinjns, G. V. Mooter.
Physicochemical characterization of solid
dispersions of the antiviral agent UC-781 with
polyethylene glycol 6000 and Gelucire 44/14,
Subhash et al., ARPB, 2014; Vol 4 (I) ISSN 2250-0774
(REVIEW ARTICLE)
589 | P a g e w w w . a r p b . i n f o
European Journal of Pharmaceutical Sciences 10:
311–322 (2000).
17. N. Rasenack, H. Hartenhauer, B. W. Muller.
Microcrystals for dissolution rate enhancement of
poorly-water soluble drugs, Int. J. Pharm. 254 (2):
137–145 (2003).
18. E. Liversidge, G. G. Liversidge, E. R. Cooper.
Nanosizing: a formulation approach for poorly
water-soluble compounds, Eur. J. Pharm. Sci. 18:
113–120 (2003).
19. S. V. Biradar, A. R. Patil, G. V. Sudarsan, V. B.
Pokharkar. A comparative study of approaches used
to improve solubility of roxithromycin, Powder
Technology 169: 22–32 (2006).
20. R. H. Muller, R. Becker, B. Kruss, K. Peters.
Pharmaceutical nanosuspensions for medicament
administration as systems with increased
saturation solubility and rate of solution, US Patent
US 5858410, January 12, 1999.
21. E. Yonemochi, S. Kitahara, S. Maeda, T. Yamamura, S.
Oguchi, K. Yamamoto. Physicochemical properties
of amorphous clarithromycin obtained by grinding
and spray drying, Eur. J. Pharm. Sci. 7: 331–338
(1999).
22. L. Chengsheng, G. Kashappa, H. Desai, L. Chenguang.
Enhancement of Dissolution Rate of Valdecoxib
using Solid Dispersions with Polyethylene Glycol
4000, Drug Development and Industrial Pharmacy
31: 1–10 (2005).
23. T. G. Fox. Influence of diluent and copolymer
composition on the glass transition temperature of
a polymer system, Bulletin of the American Physical
Society 1: 123 (1956).
24. L. J. Ford. The use of thermal analysis in the study of
solid dispersions, Drug Development and Industrial
Pharmacy 13 (9– 11): 1741–1777 (1987).
25. M. Fernandez, I. Rodriguez, M. Margarit. A. Cerezo.
Characterization of solid dispersion of
piroxicam/polyethylene glycol 4000, International
Journal of Pharmaceutics 84: 197– 202 (1992).
26. C. Liu, J. Wu, B. Shi, Y. Zhang., T. Gao, and Y. Pei.
Enhancing the Bioavailability of Cyclosporine A
using Solid Dispersion containing Polyoxyethylene
Stearate, Drug Development and Industrial
Pharmacy 32: 115–123 (2006).
27. B. C. Hancock, G. Zografi. The relationship between
the glass transition temperature and the water
content of amorphous pharmaceutical solids,
Pharmaceutical Research 11: 471–477 (1994).
28. D. Bikiaris, J. Prinos, M. Botev, M. Betchev, C.
Panayiotou. Blends of polymers with similar glass
transition temperatures: a DMTA and DSC study,
Journal of Applied Polymer Science 93: 726–735
(2004).
29. I. Weuts, D. Kempen, A. Decorte, G. Verreck, J.
Peeters, M. Brewster, G. Van den Mooter. Phase
behaviour analysis of solid dispersions of
loperamide and two structurally related
compounds with the polymers PVP-K30 and PVPVA64,
Eur J Pharm Sci. 22(5): 375-85 (2004).
30. C. D. Herzfeldt, R. Kummel. Dissociation constants,
solubilities and dissolution rates of some selected
non-steroidal anti- inflammatories, Drug
Development and Industrial Pharmacy 9: 767–793
(1983).
31. B. C. Hancock, G. Zogra. Characteristics and
significance of the amorphous state in
pharmaceutical systems (review), J. Pharm. Sci. 86:
1-12 (1997).
32. B. C. Hancock, G. Zogra. The relationship between
the glass transition temperature and the water
content of amorphous pharmaceutical solids,
Pharmaceutical Research 11: 471–477 (1994).
33. P. R. Mahaparale, V. R. Gudsoorkar, G. B. Gajeli, B. S.
Kuchekar. Studies on solid dispersions of
Meloxicam, Indian J Pharm Educ Res 40 (4): 241-45
(2006).
34. F. Lacoulonche, A. Chauvet, J. Masse. An
investigation of flurbiprofen polymorphism by
thermo-analytical and spectroscopic methods and
study of its interactions with poly (ethylene glycol)
6000 by differential scanning calorimetry and
modeling, International Journal of Pharmaceutics
153: 167–179 (1997).
Thank you for copying data from http://www.arastirmax.com